candoxatrilat has been researched along with atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)- in 1 studies
| Studies (candoxatrilat) | Trials (candoxatrilat) | Recent Studies (post-2010) (candoxatrilat) | Studies (atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-) | Trials (atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-) | Recent Studies (post-2010) (atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-) |
|---|---|---|---|---|---|
| 46 | 10 | 1 | 60 | 1 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barclay, PL; Bennett, JA; Greengrass, PM; Griffin, A; Samuels, GM; Shepperson, NB | 1 |
1 other study(ies) available for candoxatrilat and atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-
| Article | Year |
|---|---|
The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.
Topics: Amino Acid Sequence; Animals; Atrial Natriuretic Factor; Chromatography, High Pressure Liquid; Cyclohexanecarboxylic Acids; Half-Life; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Molecular Sequence Data; Nephrectomy; Neprilysin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor | 1992 |